Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Kewaunee Scientific's Depreciation and Depletion rose 9602.98% to $1.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.5 million, marking a year-over-year increase of 6875.38%. This contributed to the annual value of $4.0 million for FY2025, which is 2768.0% up from last year.
  • As of Q4 2025, Kewaunee Scientific's Depreciation and Depletion stood at $1.6 million, which was up 9602.98% from $1.5 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Depreciation and Depletion registered a high of $1.6 million during Q4 2025, and its lowest value of $659000.0 during Q1 2021.
  • In the last 5 years, Kewaunee Scientific's Depreciation and Depletion had a median value of $725000.0 in 2022 and averaged $861050.0.
  • As far as peak fluctuations go, Kewaunee Scientific's Depreciation and Depletion plummeted by 618.98% in 2021, and later surged by 9602.98% in 2025.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Depreciation and Depletion stood at $703000.0 in 2021, then grew by 0.71% to $708000.0 in 2022, then rose by 8.76% to $770000.0 in 2023, then rose by 4.68% to $806000.0 in 2024, then skyrocketed by 96.03% to $1.6 million in 2025.
  • Its Depreciation and Depletion was $1.6 million in Q4 2025, compared to $1.5 million in Q3 2025 and $806000.0 in Q2 2025.